Indeed, the main finding of our study is the observation that the soluble ICOS and ICOSL are both increased in patients with pulmonary arterial hypertension; it is particularly interesting that this finding is not dependent on the underlying cause of PAH. The gene discussed is ICOS; the disease is pulmonary arterial hypertension.